Structure, function, expression, genomic organization, and single nucleotide polymorphisms of human ABCB1 (MDR1), ABCC (MRP), and ABCG2 (BCRP) efflux transporters

被引:289
作者
Choudhuri, Supratim
Klaassen, Curtis D.
机构
[1] USDA, CFSAN, OFAS, DBGNR, College Pk, MD 20740 USA
[2] Univ Kansas, Med Ctr, Dept Pharmacol Toxicol & Therapeut, Kansas City, KS 66103 USA
关键词
P-glycoprotein; MDR; MRP; BCRP; expression; localization; SNP; function;
D O I
10.1080/10915810600746023
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
The ATP-binding cassette (ABC) transporters constitute a large family of membrane proteins, which transport a variety of compounds through the membrane against a concentration gradient at the cost of ATP hydrolysis. Substrates of the ABC transporters include lipids, bile acids, xenobiotics, and peptides for antigen presentation. As they transport exogenous and endogenous compounds, they reduce the body load of potentially harmful substances. One by-product of such protective function is that they also eliminate various useful drugs from the body, causing drug resistance. This review is a brief summary of the structure, function, and expression of the important drug resistance-conferring members belonging to three subfamilies of the human ABC family; these areABCB1(MDR1/P-glycoprotein of subfamily ABCB), subfamily ABCC (MRPs), and ABCG2 (BCRP of subfamily ABCG), which are expressed in various organs. In the text, the transporter symbol that carries the subfamily name (such as ABCB1, ABCC1, etc.) is used interchangeably with the corresponding original names, such as MDR1/P-glycoprotein, MRP1, etc., respectively. Both nomenclatures are maintained in the text because both are still used in the transporter literature. This helps readers relate various names that they encounter in the literature. It now appears that P-glycoprotein, MRP1, MRP2, and BCRP can explain the phenomenon of multidrug resistance in all cell lines analyzed thus far. Also discussed are the gene structure, regulation of expression, and various polymorphisms in these genes. Because genetic polymorphism is thought to underlie interindividual differences, including their response to drugs and other xenobiotics, the importance of polymorphism in these genes is also discussed.
引用
收藏
页码:231 / 259
页数:29
相关论文
共 50 条
[31]   Synthesis and SAR Study of Anticancer Protoflavone Derivatives: Investigation of Cytotoxicity and Interaction with ABCB1 and ABCG2 Multidrug Efflux Transporters [J].
Danko, Balazs ;
Toth, Szilard ;
Martins, Ana ;
Vagvolgyi, Mate ;
Kusz, Norbert ;
Molnar, Joseph ;
Chang, Fang-Rong ;
Wu, Yang-Chang ;
Szakacs, Gergely ;
Hunyadi, Attila .
CHEMMEDCHEM, 2017, 12 (11) :850-859
[32]   Vodobatinib overcomes cancer multidrug resistance by attenuating the drug efflux function of ABCB1 and ABCG2 [J].
Li, Yen-Ching ;
Lin, Bing-Huan ;
Murakami, Megumi ;
Wu, Yu-Shan ;
Hung, Tai-Ho ;
Chen, Chin-Chuan ;
V. Ambudkar, Suresh ;
Wu, Chung-Pu .
EUROPEAN JOURNAL OF PHARMACOLOGY, 2025, 988
[33]   GENETIC POLYMORPHISMS OF THE ADENOSINE TRIPHOSPHATE-BINDING CASSETTE TRANSPORTERS (ABCG2, ABCB1) AND GEFITINIB TOXICITY [J].
Tamura, Mariko ;
Kondo, Masashi ;
Horio, Mihoko ;
Ando, Maki ;
Saito, Hiroshi ;
Yamamoto, Masashi ;
Horio, Yoshitsugu ;
Hasegawa, Yoshinori .
NAGOYA JOURNAL OF MEDICAL SCIENCE, 2012, 74 (1-2) :133-140
[34]   Nilotinib (AMN107, Tasigna®) reverses multidrug resistance by inhibiting the activity of the ABCB1/Pgp and ABCG2/BCRP/MXR transporters [J].
Tiwari, Amit K. ;
Sodani, Kamlesh ;
Wang, Si-Rong ;
Kuang, Ye-Hong ;
Ashby, Charles R., Jr. ;
Chen, Xiang ;
Chen, Zhe-Sheng .
BIOCHEMICAL PHARMACOLOGY, 2009, 78 (02) :153-161
[35]   Influence of single nucleotide polymorphisms in ABCB1, ABCG2 and ABCC2 on clinical outcomes to paclitaxel-platinum chemotherapy in patients with non-small-cell lung cancer [J].
Qiao, Rong ;
Wu, Wenting ;
Lu, Daru ;
Han, Baohui .
INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL MEDICINE, 2016, 9 (01) :298-307
[36]   Absence of both MDR1 (ABCB1) and Breast Cancer Resistance Protein (ABCG2) Transporters Significantly Alters Rivaroxaban Disposition and Central Nervous System Entry [J].
Gong, Inna Y. ;
Mansell, Sara E. ;
Kim, Richard B. .
BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY, 2013, 112 (03) :164-170
[37]   Interplay of OATP1A/1B/2B1 uptake transporters and ABCB1 and ABCG2 efflux transporters in the handling of bilirubin and drugs [J].
Li, Wenlong ;
Sparidans, Rolf W. ;
Wang, Yaogeng ;
Martins, Margarida L. F. ;
de Waart, Dirk R. ;
van Tellingen, Olaf ;
Song, Ji-Ying ;
Lebre, Maria C. ;
Wagenaar, Els ;
Beijnen, Jos H. ;
Schinkel, Alfred H. .
BIOMEDICINE & PHARMACOTHERAPY, 2024, 175
[38]   Interactions of protease inhibitors atazanavir and ritonavir with ABCB1, ABCG2, and ABCC2 transporters: Effect on transplacental disposition in rats [J].
Cerveny, Lukas ;
Ptackova, Zuzana ;
Durisova, Marketa ;
Staud, Frantisek .
REPRODUCTIVE TOXICOLOGY, 2018, 79 :57-65
[39]   Effect of the drug transporters ABCB1, ABCC2, and ABCG2 on the disposition and brain accumulation of the taxane analog BMS-275,183 [J].
Marchetti, Serena ;
Pluim, Dick ;
Beijnen, Jos H. ;
Mazzanti, Roberto ;
van Tellingen, Olaf ;
Schellens, Jan H. M. .
INVESTIGATIONAL NEW DRUGS, 2014, 32 (06) :1083-1095
[40]   ABCB1, ABCG2, ABCC1, ABCC2, and ABCC3 drug transporter polymorphisms and their impact on drug bioavailability: what is our current understanding? [J].
Bruckmueller, Henrike ;
Cascorbi, Ingolf .
EXPERT OPINION ON DRUG METABOLISM & TOXICOLOGY, 2021, 17 (04) :369-396